LexDanaLexDanabeta
Inventor

Miles Stuart Congreve

Inventor
Cambridge, GB

Overview

74→
Patents
2005–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 74 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes27%
C07CAcyclic or carbocyclic compounds4%
C07BGeneral methods of organic chemistry2%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
C07KPeptides0%
C40BCombinatorial chemistry0%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology0%
G16CComputational chemistry0%
PatentTitleYear
11,091,456Muscarinic agonists202111,034,704Muscarinic receptor agonists202111,014,880Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists202110,995,072Inhibitors of protease-activated receptor-2202110,988,4551,2,4-triazine-4-amine derivatives202110,981,8894-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators202110,973,832Muscarinic M1 receptor agonists202110,961,225Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor202110,888,561CGRP receptor antagonists202110,759,751Substituted spirocyclohexanes as muscarinic M202010,752,610Pharmaceutical compounds202010,689,368Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor202010,584,1114-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators202010,550,089Inhibitors of protease-activated receptor-2202010,548,884Muscarinic agonists202010,428,088Muscarinic receptor agonists201910,413,553Muscarinic M1 receptor agonists201910,385,039Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonists201910,351,545Muscarinic agonists201910,329,278Pharmaceutical compounds201910,316,028Orexin receptor antagonists201910,300,056CGRP receptor antagonists201910,259,787Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists201910,259,802Bicyclic aza compounds as muscarinic M1 receptor antagonists201910,259,812CGRP receptor antagonists201910,246,4324-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators201910,196,380Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists201910,167,284Spirocyclic compounds as agonists of the muscarinic M201910,167,272Muscarinic agonists201910,166,226CGRP receptor antagonists201910,112,9231,2,4-triazine-4-amine derivatives201810,030,035Muscarinic receptor agonists201810,030,012Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists20189,975,890Bicyclic AZA compounds as muscarinic M1 receptor antagonists20189,925,178'CGRP receptor antagonists'20189,926,297'Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists'20189,914,719'Hydroxybenzamide derivatives and their use as inhibitors of HSP90'20189,907,805'Muscarinic M1 receptor agonists'20189,850,237Orexin receptor antagonists20179,808,457'CGRP receptor antagonists'20179,802,935'CGRP receptor antagonists'20179,758,506'Muscarinic agonists'20179,688,660'CGRP receptor antagonists'20179,676,745'4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators'20179,669,013'Bicyclic aza compounds as muscarinic M1 receptor agonists'20179,670,183'Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists'20179,593,106'Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists'20179,573,929'Muscarinic M1 receptor agonists'20179,555,044'Orexin receptor antagonists'20179,416,136'Pyrrolopyrimidine compounds and their uses'20169,266,857'Bicyclic AZA compounds as muscarinic M1 receptor agonists'20169,249,130'1,2,4-triazine-4-amine derivatives'20169,249,160'Orexin receptor antagonists'20169,187,451'Muscarinic M1 receptor agonists'20158,895,745'Bicyclic heterocyclic compounds as FGFR inhibitors'20148,816,087'Hydroxybenzamide derivatives and their use as inhibitors of Hsp90'20148,809,525'1,2,4-triazine-4-amine derivatives'20148,796,244'Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases'20148,779,132'Pharmaceutical compounds'20148,685,980'Pyrrolopyrimidine compounds and their uses'20148,598,217'Imidazole derivatives and their use as modulators of cyclin dependent kinases'20138,530,469'Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90'20138,513,276'Imidazo[1,2-a]pyridine compounds for use in treating cancer'20138,131,527'FGFR pharmacophore compounds'20128,106,057'Dihydroxyphenyl isoindolylmethanones'20128,101,648'Hydroxybenzamide derivatives and their use as inhibitors of HSP90'20127,855,213'Compounds'20107,754,725'Dihydroxyphenyl isoindolymethanones'20107,732,622'Naphthalene derivatives'20107,700,625'Hydroxybenzamide derivatives and their use as inhibitors of Hsp90'20107,629,356'Substituted pyrrolo[3,4-b]pyridinamines and pharmaceutical compositions'20097,166,631'Benzo[f]isoindole derivatives with affinity to the EP4 receptor'20077,149,280'Synthesis and screening of ligands using X-ray crystallography'20066,867,192'Compounds useful in the treatment of inflammatory diseases'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2018Patents assigned to ASTEX THERAPEUTICS LTD (17)· patent assignee history
2006–2021Based in Cambridge, GB· patent location history
2012–2016Patents assigned to CONGREVE MILES STUART (13)· patent assignee history
2012–2014Patents assigned to MURRAY CHRISTOPHER WILLIAM (8)· patent assignee history
2012–2014Patents assigned to CARR MARIA GRAZIA (7)· patent assignee history
2013–2014Based in Royston, GB· patent location history
2014–2021Patents assigned to HEPTARES THERAPEUTICS LTD (53)· patent assignee history
2014–2016Based in Hertfordshire, GB· patent location history
2014Based in Melbourn, GB· patent location history
2017–2019Based in Welwyn Garden City, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HEPTARES THERAPEUTICS LTD532014–2021
ASTEX THERAPEUTICS LTD172006–2018
CONGREVE MILES STUARTself132012–2016
MURRAY CHRISTOPHER WILLIAM82012–2014
CARR MARIA GRAZIA72012–2014
Locations
LocationPatentsSpan
Cambridge, GB362006–2021
Welwyn Garden City, GB262017–2019
Hertfordshire, GB52014–2016
Royston, GB52013–2014
Melbourn, GB12014